Milestone Pharmaceuticals
(NASDAQ) MIST
Milestone Pharmaceuticals Financials at a Glance
Market Cap
$237.69M
Revenue (TTM)
$1.55M
Net Income (TTM)
$63.06M
EPS (TTM)
$-0.80
P/E Ratio
-2.54
Dividend
$0.00
Beta (Volatility)
1.08 (Average)
Dividend
$0.00
Beta (Volatility)
1.08 (Average)
Price
$2.02
Volume
78,338
Open
$2.06
Price
$2.02
Volume
78,338
Open
$2.06
Previous Close
$2.02
Daily Range
$1.97 - $2.14
52-Week Range
$0.77 - $3.06
Dividend
$0.00
Beta (Volatility)
1.08 (Average)
Price
$2.02
Volume
78,338
Open
$2.06
Previous Close
$2.02
Daily Range
$1.97 - $2.14
52-Week Range
$0.77 - $3.06
MIST News
MIST: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Milestone Pharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareEmployees
38
CEO
Joseph G. Oliveto, MBA
Website
www.milestonepharma.comHeadquarters
Montreal, QC H4M 2X6, CA
MIST Financials
Key Financial Metrics (TTM)
Gross Margin
96%
Operating Margin
-40%
Net Income Margin
-41%
Return on Equity
-230%
Return on Capital
-63%
Return on Assets
-56%
Earnings Yield
-39.37%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$237.69M
Shares Outstanding
117.67M
Volume
78.34K
Short Interest
0.00%
Avg. Volume
2.33M
Financials (TTM)
Gross Profit
$1.43M
Operating Income
$62.48M
EBITDA
$62.14M
Operating Cash Flow
$49.04M
Capital Expenditure
$302.00K
Free Cash Flow
$49.34M
Cash & ST Invst.
$105.96M
Total Debt
$58.38M
Milestone Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.55M
N/A
Gross Profit
$1.51M
+366.7%
Gross Margin
97.80%
N/A
Market Cap
$237.69M
N/A
Market Cap/Employee
$7.20M
N/A
Employees
33
N/A
Net Income
$17.41M
-40.8%
EBITDA
$17.32M
-58.3%
Quarterly Fundamentals
Net Cash
$47.58M
+219.4%
Accounts Receivable
$3.51M
+46.7%
Inventory
$648.00K
N/A
Long Term Debt
$57.73M
+6.5%
Short Term Debt
$647.00K
+13.3%
Return on Assets
-55.53%
N/A
Return on Invested Capital
-62.57%
N/A
Free Cash Flow
$12.79M
-86.2%
Operating Cash Flow
$12.78M
-86.7%